Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P190023/S029

Navitor TAVI System with Vision Technology

ABBOTT MEDICAL · Decision date Jun 3, 2026

FDA DECISIONP190023/S029

What did the FDA approve?

FDA records P190023/S029 as a supplement to PMA P190023, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Jun 3, 2026.

FDA approval order statement

approval for modifications to the Instructions for Use to reflect the 5-year findings of the Post-Approval Study (PAS) Report submitted for the long term follow-up of the Portico TAVI System prospective cohort study
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Cardiovascular
Decision date
Jun 3, 2026
FDA change category
Labeling Change - PAS

FDA source record

Regulatory record facts

Identifier
P190023/S029
Regulatory pathway
PMA supplement
Product code
NPT
Decision code
APPR
Decision date
Jun 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Aortic valve, prosthesis, percutaneously delivered.

Product code
NPT
FDA device class
3

For the original device and its historical approval scope, see PMA P190023. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P190023 · Original PMA

    Portico Transcatheter Aortic Valve Implantation System

  2. P190023/S026 · Related supplement

    Navitor Transcatheter Aortic Valve

  3. P190023/S027 · Related supplement

    Navitor Transcatheter Aortic Valve Implantation System

  4. P190023/S028 · Related supplement

    FlexNav Delivery System; Navitor Transcatheter Aortic Valves

  5. P190023/S029 received

    Application receipt date recorded by FDA.

  6. P190023/S031 · Related supplement

    Navitor Transcatheter Aortic Valve Implantation System

  7. P190023/S030 · Related supplement

    Navitor Transcatheter Aortic Valve Implantation System

  8. P190023/S032 · Related supplement

    Navitor Transcatheter Aortic Valve Implantation System

  9. P190023/S029 · FDA decision

    Normal 180 Day Track No User Fee

  10. P190023/S034 · Related supplement

    Navitor Transcatheter Aortic Valve Implantation System

  11. P190023/S033 · Related supplement

    Navitor Transcatheter Aortic Valve Implantation System

Timeline entries are records held by MedtechLedger for P190023. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P190023

Explore the linked device profile

Other records with product code NPT

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
177 County Rd. B E., St. Paul, MN, 55117

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records